SOLIGENIX, INC. Line of Credit Facility, Remaining Borrowing Capacity
SOLIGENIX, INC. (SNGX) had Line of Credit Facility, Remaining Borrowing Capacity of $4.30 million as of 2017-09-30, per its 10-Q filed 2017-11-06.
Discontinued › Notes › Debt › Line of Credit Facility
us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity · last filed 2017-11-06
- 2017-09-30: Line of Credit Facility, Remaining Borrowing Capacity $4.30M.
| Period end | Line of Credit Facility, Remaining Borrowing Capacity |
|---|---|
| 2017-09-30 | $4.30M 10-Q · filed 2017-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |